Solara Active

{
  "main_header": {
    "sid": 1003017,
    "name": "Solara Active",
    "stock_name": "Solara Active",
    "full_name": "Solara Active Pharma Sciences Ltd",
    "name_url": "stocks-analysis/solara-active",
    "exchange": 1,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "470.85",
    "chg": -55.6,
    "chgp": "-10.56%",
    "dir": -1,
    "prev_price": "526.45",
    "mcapval": "1,897.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 541540,
    "symbol": "SOLARA",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE624Z01016",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "4.3 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/solara-active-1003017-1&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Are Solara Active Pharma Sciences Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-solara-active-pharma-sciences-ltd-latest-results-good-or-bad-3824942",
        "imagepath": "",
        "date": "2026-02-06 19:29:45",
        "description": "Solara Active Pharma Sciences Ltd's latest financial results reveal a complex picture of operational performance. In Q2 FY26, the company reported a net profit of ₹10.52 crores, a significant turnaround from a loss of ₹2.10 crores in the previous quarter. This sequential improvement in profitability was accompanied by a quarter-on-quarter revenue increase of 16.90%, reaching ₹319.15 crores. However, year-on-year comparisons indicate a decline in net sales by 12.20% from ₹363.49 crores in Q2 FY25, highlighting ongoing challenges in revenue generation.\n\nThe operating margin for the quarter improved to 17.87%, up from 16.62% in Q1 FY26, suggesting some success in cost management despite remaining below the 19.21% achieved in Q3 FY25. Nevertheless, the return on equity (ROE) remains low at 2.80%, indicating weak capital efficiency and raising concerns about the company's ability to generate adequate returns on ..."
      },
      {
        "title": "Solara Active Pharma Q3 FY26: Margin Compression Triggers Sharp Loss Despite Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/solara-active-pharma-q3-fy26-margin-compression-triggers-sharp-loss-despite-revenue-growth-3824976",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SolaraActivePha_quaterlyResult_3824976.png",
        "date": "2026-02-06 17:23:23",
        "description": "Solara Active Pharma Sciences Ltd., a small-cap pharmaceutical manufacturer specialising in active pharmaceutical ingredients (APIs), reported a disappointing Q3 FY26 performance marked by severe margin compression that overshadowed revenue growth. The company posted a net loss of ₹17.43 crores for the quarter ended December 2025, a sharp deterioration from the ₹10.52 crores profit recorded in Q2 FY26 and significantly worse than the ₹8.09 crores profit in Q3 FY25. The stock plummeted 10.10% to ₹471.20 following the results, reflecting investor concerns about the company's profitability trajectory despite a ₹1,897 crore market capitalisation."
      },
      {
        "title": "Solara Active Pharma Sciences Ltd Hits Intraday Low Amid Price Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/solara-active-pharma-sciences-ltd-hits-intraday-low-amid-price-pressure-3824544",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SolaraActivePha_priceRelatedfactors_3824544.png",
        "date": "2026-02-06 15:03:12",
        "description": "Solara Active Pharma Sciences Ltd experienced a significant intraday decline on 6 Feb 2026, touching a low of Rs 482.2, down 8.06% from the previous close. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure and heightened volatility."
      },
      {
        "title": "Solara Active Pharma Sciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/solara-active-pharma-sciences-ltd-is-rated-strong-sell-3824193",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/SolaraActivePha_mojoScore_3824193.png",
        "date": "2026-02-06 10:10:03",
        "description": "Solara Active Pharma Sciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook."
      },
      {
        "title": "Solara Active Pharma Sciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/solara-active-pharma-sciences-ltd-is-rated-strong-sell-3804684",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SolaraActivePha_mojoScore_3804684.png",
        "date": "2026-01-26 10:10:05",
        "description": "Solara Active Pharma Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 December 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are based on the company’s current position as of 26 January 2026, providing investors with the latest comprehensive view."
      },
      {
        "title": "Why is Solara Active Pharma Sciences Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-solara-active-pharma-sciences-ltd-fallingrising-3795054",
        "imagepath": "",
        "date": "2026-01-20 01:02:58",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Movement and Market Performance</strong></p>\n<p>Solara Active Pharma has been on a downward trajectory over the past week, losing 3.15% compared to the Sensex’s modest 0.75% decline. The trend extends over the last month and year, with the stock falling 6.90% and 20.25% respectively, while the Sensex gained 8.65% over the same one-year period. Year-to-date, the stock has dropped 5.44%, underperforming the benchmark index’s 2.32% fall. This persistent underperformance highlights investor concerns about the company’s prospects relative to the broader market.</p>\n<p>On the day in question, the stock underperformed its sector by 2.03%, marking its third consecutive day of losses and a cumulative decline of 5.63% over this period. Intraday, the share price touched a low of ₹530, down..."
      },
      {
        "title": "Solara Active Pharma Sciences Ltd is Rated Strong Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/solara-active-pharma-sciences-ltd-is-rated-strong-sell-3792892",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SolaraActivePha_mojoScore_3792892.png",
        "date": "2026-01-15 10:10:03",
        "description": "Solara Active Pharma Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 15 January 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Solara Active Pharma Sciences Ltd Sees Mixed Technical Signals Amid Mildly Bearish Momentum",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/solara-active-pharma-sciences-ltd-sees-mixed-technical-signals-amid-mildly-bearish-momentum-3791395",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SolaraActivePha_technicaldot_3791395.png",
        "date": "2026-01-14 08:03:33",
        "description": "Solara Active Pharma Sciences Ltd has experienced a nuanced shift in its technical momentum, moving from a bearish to a mildly bearish stance across key indicators. Despite a modest day gain of 2.58%, the stock’s broader technical signals and relative performance against the Sensex suggest cautious investor sentiment amid mixed momentum cues."
      },
      {
        "title": "Solara Active Pharma Sciences Ltd Faces Bearish Momentum Amid Technical Downgrade",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/solara-active-pharma-sciences-ltd-faces-bearish-momentum-amid-technical-downgrade-3786418",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/SolaraActivePha_technicaldot_3786418.png",
        "date": "2026-01-09 08:08:35",
        "description": "Solara Active Pharma Sciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s stock price has declined to ₹561.45, down 1.59% from the previous close of ₹570.50, reflecting growing investor caution amid weakening technical signals and a downgrade in its overall mojo rating to Strong Sell."
      }
    ],
    "total": 614,
    "sid": "1003017",
    "stock_news_url": "https://www.marketsmojo.com/news/solara-active-pharma-sciences-1003017"
  },
  "announcements": [
    {
      "details": "Solara Active Pharma Sciences Limited has informed the Exchange regarding a press release dated December 09, 2019, titled \"Appointment of Mr. Bharath R. Sesha Chief Executive Officer.\".",
      "source": "NSE",
      "caption": "Solara Active Pharma Sciences Limited - Press Release",
      "datetime": "09-Dec-2019"
    },
    {
      "details": "Solara Active Pharma Sciences Limited has informed the Exchange regarding allotment of 248000 Equity Shares under ESOP",
      "source": "NSE",
      "caption": "Solara Active Pharma Sciences Limited - Allotment of ESOP/ESPS",
      "datetime": "03-Dec-2019"
    },
    {
      "details": "Solara Active Pharma Sciences Limited has informed the Exchange that Disclosure of Related Party Transactions pursuant to Regulation 23(9) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015",
      "source": "NSE",
      "caption": "Solara Active Pharma Sciences Limited - Other General Purpose",
      "datetime": "21-Nov-2019"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "",
      "data": [
        {
          "title": "BOARD MEETING",
          "txt": "(06 Feb 2026)"
        }
      ]
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Solara Active Pharma Sciences Ltd has declared <strong>30%</strong> dividend, ex-date: 18 Aug 21",
          "dt": "2021-08-18",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Solara Active Pharma Sciences Ltd has announced <strong>1:3</strong> rights issue, ex-date: 15 May 24",
          "dt": "2024-05-15",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Are Solara Active Pharma Sciences Ltd latest results good or bad?

2026-02-06 19:29:45

Solara Active Pharma Sciences Ltd's latest financial results reveal a complex picture of operational performance. In Q2 FY26, the company reported a net profit of ₹10.52 crores, a significant turnaround from a loss of ₹2.10 crores in the previous quarter. This sequential improvement in profitability was accompanied by a quarter-on-quarter revenue increase of 16.90%, reaching ₹319.15 crores. However, year-on-year comparisons indicate a decline in net sales by 12.20% from ₹363.49 crores in Q2 FY25, highlighting ongoing challenges in revenue generation. The operating margin for the quarter improved to 17.87%, up from 16.62% in Q1 FY26, suggesting some success in cost management despite remaining below the 19.21% achieved in Q3 FY25. Nevertheless, the return on equity (ROE) remains low at 2.80%, indicating weak capital efficiency and raising concerns about the company's ability to generate adequate returns on ...

Read full news article

Solara Active Pharma Q3 FY26: Margin Compression Triggers Sharp Loss Despite Revenue Growth

2026-02-06 17:23:23

Solara Active Pharma Sciences Ltd., a small-cap pharmaceutical manufacturer specialising in active pharmaceutical ingredients (APIs), reported a disappointing Q3 FY26 performance marked by severe margin compression that overshadowed revenue growth. The company posted a net loss of ₹17.43 crores for the quarter ended December 2025, a sharp deterioration from the ₹10.52 crores profit recorded in Q2 FY26 and significantly worse than the ₹8.09 crores profit in Q3 FY25. The stock plummeted 10.10% to ₹471.20 following the results, reflecting investor concerns about the company's profitability trajectory despite a ₹1,897 crore market capitalisation.

Read full news article

Solara Active Pharma Sciences Ltd Hits Intraday Low Amid Price Pressure

2026-02-06 15:03:12

Solara Active Pharma Sciences Ltd experienced a significant intraday decline on 6 Feb 2026, touching a low of Rs 482.2, down 8.06% from the previous close. The stock underperformed its sector and broader market indices, reflecting immediate selling pressure and heightened volatility.

Read full news article

Solara Active Pharma Sciences Ltd is Rated Strong Sell

2026-02-06 10:10:03

Solara Active Pharma Sciences Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 23 December 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 06 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Solara Active Pharma Sciences Ltd is Rated Strong Sell

2026-01-26 10:10:05

Solara Active Pharma Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 December 2025, reflecting a significant reassessment of the stock’s outlook. However, all fundamentals, returns, and financial metrics discussed below are based on the company’s current position as of 26 January 2026, providing investors with the latest comprehensive view.

Read full news article

Why is Solara Active Pharma Sciences Ltd falling/rising?

2026-01-20 01:02:58

Recent Price Movement and Market Performance

Solara Active Pharma has been on a downward trajectory over the past week, losing 3.15% compared to the Sensex’s modest 0.75% decline. The trend extends over the last month and year, with the stock falling 6.90% and 20.25% respectively, while the Sensex gained 8.65% over the same one-year period. Year-to-date, the stock has dropped 5.44%, underperforming the benchmark index’s 2.32% fall. This persistent underperformance highlights investor concerns about the company’s prospects relative to the broader market.

On the day in question, the stock underperformed its sector by 2.03%, marking its third consecutive day of losses and a cumulative decline of 5.63% over this period. Intraday, the share price touched a low of ₹530, down...

Read full news article

Solara Active Pharma Sciences Ltd is Rated Strong Sell

2026-01-15 10:10:03

Solara Active Pharma Sciences Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 23 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 15 January 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Solara Active Pharma Sciences Ltd Sees Mixed Technical Signals Amid Mildly Bearish Momentum

2026-01-14 08:03:33

Solara Active Pharma Sciences Ltd has experienced a nuanced shift in its technical momentum, moving from a bearish to a mildly bearish stance across key indicators. Despite a modest day gain of 2.58%, the stock’s broader technical signals and relative performance against the Sensex suggest cautious investor sentiment amid mixed momentum cues.

Read full news article

Solara Active Pharma Sciences Ltd Faces Bearish Momentum Amid Technical Downgrade

2026-01-09 08:08:35

Solara Active Pharma Sciences Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s stock price has declined to ₹561.45, down 1.59% from the previous close of ₹570.50, reflecting growing investor caution amid weakening technical signals and a downgrade in its overall mojo rating to Strong Sell.

Read full news article

View All News